Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

The re-colonization of the microbiome in Crohn’s Disease

EF 2017-18

Résumé
Crohn's Disease (CD) is a chronic illness in which the entire digestive tract can become inflamed and damaged. Genetics, the environment, gut microbes and a dysregulation of the immune response are factors thought to underlie pathogenesis. Patients with CD suffer from diarrhea, malnutrition, and chronic pain. In severe cases of CD, patients may require invasive surgeries to remove sections of their intestine, further complicating their health. Globally, Canada has one the highest incidence rates of CD and has been estimated to cost Canadians $1.75 billion each year through direct and indirect costs. Presently, the cause of CD is still unclear and there is no cure. Continued basic research is required to discover new targets for therapy to improve patient health. While microorganisms are mostly known for their role in causing disease and illnesses, the intestines of the digestive tract are home to a great collection of bacteria, known as the microbiome. Normally, these bacteria are responsible for maintaining human health by providing essential vitamins, digesting food, and aiding in protection against harmful microorganisms. Interestingly, patients with CD have been shown to have an altered microbiome that plays a role in its disease. As such, the goal of this project is to study the microbiome in the context of CD. The hypothesis of this study is that re-colonizing the intestine of CD patients with a customized combination of beneficial bacteria will help in resetting the microbiome and limit the growth of harmful microorganisms to improve patient health. We will use a combination of fecal microbiota transplant, custom microbiome consortia design and germ-free mice to establish a causative link between microbes and disease development.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
386487
Name
Tsang Derek K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The re-colonization of the microbiome in Crohn’s Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Colitis; Dysbiosis; Gastroenterology; Immunology; Microbiology; Microbiome
Abstract
Crohn's Disease (CD) is a chronic illness in which the entire digestive tract can become inflamed and damaged. Genetics, the environment, gut microbes and a dysregulation of the immune response are factors thought to underlie pathogenesis. Patients with CD suffer from diarrhea, malnutrition, and chronic pain. In severe cases of CD, patients may require invasive surgeries to remove sections of their intestine, further complicating their health. Globally, Canada has one the highest incidence rates of CD and has been estimated to cost Canadians $1.75 billion each year through direct and indirect costs. Presently, the cause of CD is still unclear and there is no cure. Continued basic research is required to discover new targets for therapy to improve patient health. While microorganisms are mostly known for their role in causing disease and illnesses, the intestines of the digestive tract are home to a great collection of bacteria, known as the microbiome. Normally, these bacteria are responsible for maintaining human health by providing essential vitamins, digesting food, and aiding in protection against harmful microorganisms. Interestingly, patients with CD have been shown to have an altered microbiome that plays a role in its disease. As such, the goal of this project is to study the microbiome in the context of CD. The hypothesis of this study is that re-colonizing the intestine of CD patients with a customized combination of beneficial bacteria will help in resetting the microbiome and limit the growth of harmful microorganisms to improve patient health. We will use a combination of fecal microbiota transplant, custom microbiome consortia design and germ-free mice to establish a causative link between microbes and disease development.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tsang, Derek K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~